Description: The author discusses the Genetic Information Nondiscrimination Act of 2008 GINA and its ultimate effect on the long-term care industry in general, and on current and future insureds, specifically.

Description: An insurance company selling LTCI today would do far better to address some important financial needs by taking the aspirin of improving modeling and pricing, and not the morphine of shutting down the business line entirely. The aspirin can consist of two strategies: First, integrate the projections of the asset portfolio and the claims liabilities when testing the sensitivity of assumptions or stochastically modeling the product. Second, establish a separate asset portfolio for LTCI products, and make sure it has a strong, well-defined, well-documented Investment Policy Statement. An Investment Policy Statement will enable pricing actuaries and investment departments to work together with the same goals and objectives.

Description: Methodology for identifying principles based economic capital.

Description: New insurance product concept to cover elder care

Description: This article discusses the ways reinsurers support ceding companies: 1. Sharing morbidity risk. 2. Sharing other risks such as return on investment. 3. Sharing of expertise such as providing underwriting advice. 4. Sharing financial resources. 5. Sharing the role of consumer protection.

Description: An introduction to other articles in this issue about Medicaid abuse and genetic testing.

Description: Full version of Long-Term Care Newsletter, August 2003, Issue No. 9.

Description: Recommendation to measure the risk for the components of combination Life/LTC products.

Description: To penetrate the market of those who today are concerned about future long-term care needs, LTCI providers will need to combine strategies for financial sustainability with the consumer- driven product design focus of the early to mid-1990s.

Description: Full version of Long-Term Care Newsletter, August 2001, Issue No. 5.